Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma

BACKGROUND: Transcatheter arterial chemoembolisation (TACE) is the treatment of choice for intermediate stage hepatocellular carcinoma (HCC). Doxorubicin-loaded drug-eluting beads (DEB)-TACE is expected to improve the performance of conventional TACE (cTACE). The aim of this study was to compare DEB...

詳細記述

保存先:
書誌詳細
主要な著者: Golfieri, R, Giampalma, E, Renzulli, M, Cioni, R, Bargellini, I, Bartolozzi, C, Breatta, A D, Gandini, G, Nani, R, Gasparini, D, Cucchetti, A, Bolondi, L, Trevisani, F
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2014
主題:
Clinical Study
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4102934/
https://ncbi.nlm.nih.gov/pubmed/24937669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.199
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料